News
The ′Osteochip Project′ involded more than 1,700 post-menopause women aged 45 and older from France, Switzerland and Italy. This study is being developed by Bioiberica Farma, a leading Spanish biotechnology company with more than 30 years of experience in joint care under its belt. Dr.
Nearly 17% of the Andalusian population suffers from osteoarthritis, a disease that causes 35% of primary care visitsExperts will meet next Thursday in Malaga to discuss this disease and the role that pharmacists can play in monitoring its development
The US Authorities inspected the facilities related to the production of heparin in the plants of Palafolls and Probisa.
Bioiberica and Natural Ingredients signed an agreement for the marketing of Nucleoforce in Spain.
It is one of the most important aquaculture industry events in Latin America, and took place on October 22nd, 2012